All returns discussed below are measured from the disclosure date forward. This means the public could have seen each of these positions when they were filed and acted on the same information available to everyone else. Congressional trading disclosures continue to surface notable outperformers, with four House members posting triple-digit gains across sectors including technology, healthcare and consumer cyclical. The latest data set highlights both verified results and positions flagged for additional review.
Rep. Lisa McClain, a Michigan Republican, bought SNDK with the purchase disclosed on November 21, 2025. This position is an outlier we are still verifying at a return of 892.2 percent. Similarly, California Democrat Ro Khanna recorded two purchases that remain under review. His CCG buy, disclosed February 6, 2026, shows a return of 866.67 percent while his MRNA transaction disclosed January 6, 2026 registers 525.29 percent. These three trades require further corroboration before final performance numbers can be locked.
The verified positions deliver equally striking numbers. McClain also purchased CIEN, disclosed August 13, 2025, which has returned 374.61 percent. North Carolina Republican Tim Moore bought TZA with disclosure on July 9, 2025 for a 276.8 percent gain. California Democrat Scott H. Peters purchased KSS, disclosed May 16, 2025, producing a 275.96 percent return. Each of these filings fell within standard $1,001-$50,000 ranges typical of congressional disclosures and covered distinct sectors from communication services to consumer cyclical.
What stands out is the breadth of names and the fact that both parties appear. Technology names dominate the upper end while the consumer and healthcare picks demonstrate that the pattern is not confined to a single industry. Because every trade was visible on its disclosure date, retail investors tracking senate.gov and house ethics filings had the same opportunity to observe these moves in real time. The cluster adds to a growing list of post-filing performance that warrants continued monitoring as new filings arrive.
With market volatility likely to persist through upcoming policy debates and earnings cycles, these examples illustrate why some investors pay close attention to the timing of disclosed congressional activity. Whether the verified returns can be replicated remains to be seen, but the data provides a clear record of what actually happened after each filing became public. This is data analysis, not financial advice.
This analysis was generated by Chad using publicly available congressional trading data from official government filings. This is not financial advice. All data is sourced from senate.gov, clerk.house.gov, and SEC EDGAR.